영업양도에 따른 개인정보 이전 안내

Abbott Korea Limited (“Company”) is scheduled to transfer its Vascular and Structural Heart business (“Transferred Business) to Abbott Medical Korea Limited on October 4, 2021 (the “Business Transfer”).

As a result of this Business Transfer, personal information of customers and trading counterparties which the Company has retained in connection with the Transferred Business as well as that of officers and employees of the Company who performed business in connection with the Transferred Business will be transferred to Abbott Medical Korea Limited. Abbott Medical Korea Limited will manage such personal information securely and use, provide and process the personal information only for the original purpose at the time of the transfer. Should you have any objections, inquiries or need further information in this regard, you may reach our contact point in charge of personal information as follows:

Name: [Suh, DongEun]
Department and title: [OEC Compliance manager]
Telephone No.: [82-2-3429-3532]
E-mail: [dongeun.suh@abbott.com]

Information on Abbott Medical Korea Limited which will receive the personal information is as follows:

Company: Abbott Medical Korea Limited
Address: 337, Eonju-ro, Gangnam-gu, Seoul, Republic of Korea
Telephone No.: [82-2-6909-2500]
E-mail: [jingyung.kim@abbott.com]   

          September 27, 2021

                                                                    Representative Director: Rodrigo Mazon